Abstract:
ACLARA BioSciences and the USC/Norris Comprehensive Cancer Center and Hospital, announced today a research partnership to identify and characterize novel clinical biomarkers for cancer. The partners will initially apply ACLARA's proprietary multiplexed eTag(TM) Assay System to the discovery of novel biomarkers for breast cancer.